1 |
Dominik Zenner,Daniella Brals,Joanna Nederby-Öhd,et al.Drivers determining tuberculosis disease screening yield in four European screening programmes: a comparative analysis[J].Eur Respir J,2023,62(4): 2202396.
|
2 |
Bagcchi S.WHO′s Global Tuberculosis Report 2022[J].Lancet Microbe,2023,4(1): e20.
|
3 |
Waganeh Sinshaw,Abebaw Kebede,Adane Bitew,et al.Prevalence of tuberculosis,multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa,Ethiopia[J].BMC Infect Dis,2019,19(1): 641.
|
4 |
Francesca Wanda Basile,Sedona Sweeney,Maninder Pal Singh,et al.Uncertainty in tuberculosis clinical decision-making: An umbrella review with systematic methods and thematic analysis[J].PLOS Glob Public Health,2024,4(7): e0003429.
|
5 |
Tariro Christwish Mando,Charles Sandy,Addmore Chadambuka,et al.Tuberculosis cohort analysis in Zimbabwe: The need to strengthen patient follow-up throughout the tuberculosis care cascade[J].PLoS One,2023,18(11): e0293867.
|
6 |
Narjes Jafari,Saeid Abediankenari.Abediankenari,Role of microRNAs in immunoregulatory functions of epithelial cells[J].BMC Immunol,2024,25(1): 84.
|
7 |
Abualgasim Elgaili Abdalla,Awadh Alanazi,Khalid Omer Abdalla Abosalif,et al.MicroRNA-155,a double-blade sword regulator of innate tuberculosis immunity [J].Microb Pathog,2023,185:106438.
|
8 |
Evangeline Ann Daniel,Balakumaran Sathiyamani,Kannan Thiruvengadam,et al.MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysis[J].Front Immunol,2022,13: 954396.
|
9 |
Piyush Agrawal,Aditya Upadhyay,Awanish Kumar.Kumar,microRNA as biomarkers in tuberculosis: a new emerging olecular diagnostic solution[J].Diagn Microbiol Infect Dis,2024,108(1): 116082.
|
10 |
Feng Sun,Jiangbo Li,Ling Cao,et al.Mycobacterium tuberculosis virulence protein ESAT-6 influences M1/M2 polarization and macrophage apoptosis to regulate tuberculosis progression[J].Genes Genomics,2024,46(1): 37-47.
|
11 |
Jagadeeswara Rao Muvva,Venkata Ramanarao Parasa,Maria Lerm,et al.Polarization of Human Monocyte-Derived Cells With Vitamin D Promotes Control of Mycobacterium tuberculosis Infection[J].Front Immunol,2019,10: 3157.
|
12 |
Rizk Sayad R Sarhan,Omnia Y Habashy,Raafat R Mohammed,et al.Active versus latent pulmonary tuberculosis: which one is the appropriate distinguishing biomarker[J].Monaldi Arch Chest Dis,2024,doi: 10.4081/monaldi.2024.2947.
|
13 |
Hyun Jin Cho,Yun-Ji Lim,Jhingook Kim,et al.Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis[J].BMC Infect Dis,2020,20(1): 81.
|
14 |
Zhangli Peng,Ling Chen,Hong Zhang.Serum proteomic analysis of Mycobacterium tuberculosis antigens for discriminating active tuberculosis from latent infection[J].J Int Med Res,2020,48(3):300060520910042.
|
15 |
Torres T,Brembilla NC,Langley RG,et al.Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus[J].J Eur Acad Dermatol Venereol,2025,39(1): 52-69.
|
16 |
Rashad Abdul-Ghani,Asmaa Al-Awadi,Nuha Al-Aghbari,et al.Latent tuberculosis infection and diagnostic performance of the tuberculin skin test among type 2 diabetics in Sana′a city,Yemen[J].BMC Infect Dis,2024,24(1): 1005.
|
17 |
Monica Pagnoncelli,Marco Arosio,Alessandro Genovesi,et al.Performance of the T-SPOT.TB test in patients with indeterminate QuantiFERON-TB Gold Plus results: proposal for an algorithm for the diagnosis of Latent Tuberculosis Infection[J].Infez Med,2024,32(4): 525-531.
|
18 |
Antony M Rapulana,Thabo Mpotje,Omolara O Baiyegunhi,et al.Combined analysis of host IFN-γ,IL-2 and IP-10 as potential LTBI biomarkers in ESAT-6/CFP-10 stimulated blood[J].Front Mol Med,2024,4: 1345510.
|
19 |
Yuanchun Li,Zhengrong Yang,Qiping Ge,et al.Specific cytokines analysis Incorporating latency-associated antigens differentiates Mycobacterium tuberculosis infection status: an exploratory study[J].Infect Drug Resist,2024,17: 3385-3393.
|
20 |
Qingqing Shan,Yangke Li,Kun Yuan,et al.Distinguish active tuberculosis with an immune-related signature and molecule subtypes: a multi-cohort analysis[J].Sci Rep,2024,14(1):29564.
|
21 |
Chih-Jung Chang,Jhong-Ru Huang,Yen-Han Tseng,et al.Global cell-free DNA methylation in patients with active tuberculosis and tuberculosis contacts with latent tuberculosis infection[J].Diagn Microbiol Infect Dis,2025,111(1): 116559.
|
22 |
Joyita Banerjee,Swagata Roy,Yogita Dhas,et al.Senescenceassociated miR-34a and miR-126 in middle-aged Indians with type 2 diabetes[J].Clin Exp Med,2020,20(1): 149-158.
|
23 |
Daniel EA,Sathiyamani B,Thiruvengadam K,et al.miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis[J].Front Public Health,2024,12: 1384510.
|
24 |
Zhicheng Sun,Xiaoyang Pang,Xiyang Wang,et al.Differential expression analysis of miRNAs in macrophage-derived exosomes in the tuberculosis-infected bone microenvironment [ J ].Front Microbiol,2023,14: 1236012.
|
25 |
Gwenda F Vasse,Mehmet Nizamoglu,Irene H Heijink,et al.Macrophage-stroma interactions in fibrosis: biochemical,biophysical,and cellular perspectives[J].J Pathol,2021,254(4): 344-357.
|
26 |
Xiangyi Kong,Jun Gao.Macrophage polarization:a key event in the secondary phase of acute spinal cord injury[J].J Cell Mol Med,2017,21(5): 941-954.
|
27 |
Chen S,Saeed AFUH,Liu Q,et al.Macrophages in immunoregulation and therapeutics[J].Signal Transduct Target Ther,2023,8(1):207.
|
28 |
Renhao Ni,Lingjing Jiang,Chaohai Zhang,et al.Biologic mechanisms of macrophage phenotypes responding to infection and the novel therapies to moderate inflammation[J].Int J Mol Sci,2023,24(9): 8358.
|
29 |
Malika Ali,Marcel Bonay,Valentin Vanhee,et al.Comparative effectiveness of 4 natural and chemical activators of Nrf2 on inflammation,oxidative stress,macrophage polarization,and bactericidal activity in an in vitro macrophage infection model[J].PLoS One,2020,15(6): e0234484.
|
30 |
Wang S,Cao M,Xu S,et al.Luteolin alters macrophage polarization to inhibit inflammation[J].Inflammation,2020,43(1): 95-108.
|
31 |
Alyson A Fiorillo,Christopher R Heier,Yu-Fang Huang,et al.Estrogen Receptor,Inflammatory,and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs[J].Front Immunol,2020,11: 151.
|
32 |
Sanjaya Kumar Sahu,Manish Kumar,Sohini Chakraborty,et al.MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling,the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection[J].PLoS Pathog,2017,13(5): e1006410.
|
33 |
Ruiying Wang,Zhifan Zhu,Shisheng Peng,et al.Exosome microRNA-125a-5p derived from epithelium promotes M1 macrophage polarization by targeting IL1RN in chronic obstructive pulmonary disease[J].Int Immunopharmacol,2024,137: 112466.
|
34 |
Ying Peng,Xian-Jin Wu,Xue-Jiao Ji,et al.Circular RNA circTRAPPC6B Enhances IL-6 and IL-1β Expression and Repolarizes Mycobacteria Induced Macrophages from M2- to M1-Like Phenotype by Targeting miR-892c-3p[J].J Interferon Cytokine Res,2023,43(6): 269-279.
|
35 |
Jun Lou,Yongli Wang,Zhimin Zhang,et al.MiR-20b inhibits mycobacterium tuberculosis induced inflammation in the lung of mice through targeting NLRP3[J].Exp Cell Res,2017,358(2):120-128.
|
36 |
Huang Z,Gao C,Chi X,et al.IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype[J].Scand J Immunol,2015,82(4): 370-379.
|